BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Solve ME/CFS Initiative - ECPv6.15.17//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://solvecfs.org
X-WR-CALDESC:Events for Solve ME/CFS Initiative
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260115T090000
DTEND;TZID=America/Los_Angeles:20260115T100000
DTSTAMP:20260717T174841
CREATED:20251028T001815Z
LAST-MODIFIED:20251028T001815Z
UID:42923-1768467600-1768471200@solvecfs.org
SUMMARY:From Mystery to Measurable: The Science Behind the New ME/CFS Blood Test
DESCRIPTION:For the first time\, scientists have developed a simple\, accurate blood test that can potentially identify Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) — a long-term\, debilitating condition that affects millions of patients worldwide.  \nThe study (published in the Journal of Translational Medicine)\, led by the University of East Anglia in partnership with Oxford BioDynamics\, used cutting-edge 3D genomic technology to look at how DNA is folded inside blood cells. Just like origami\, the shape and folds of DNA control which genes are switched on or off.  \nThe team discovered a distinctive pattern of these folds that appears only in people with ME/CFS — providing a clear biological “fingerprint” of the disease. Using this pattern\, the researchers created a blood test that can diagnose ME/CFS with 96% accuracy. Until now\, doctors have had to rely on symptoms alone and rule out other illnesses\, a process that can take years. This test offers the potential for quicker\, more confident diagnoses and could end the uncertainty many patients face. \nBeyond diagnosis\, the findings also point toward disrupted immune and inflammation pathways\, which may help scientists develop targeted treatments in the future. The same approach could even pave the way for a similar test for Long Covid\, which shares many of the same biological features as ME/CFS. \nThis discovery marks an important turning point: it brings scientific validation to patients whose symptoms have too often been dismissed\, and it opens the door to better understanding\, earlier support\, and more effective care for people living with this complex condition. \nIn this webinar\, Solve CEO Emily Taylor will host research team members Dr. Dmitry Pshezhetskiy (University of East Anglia)\, Dr. Alexandre Akoulitchev\, MA\, PhD\, FRSM (Chief Scientific Officer\, Oxford BioDynamics)\, Bartu Ahiska (Senior Director\, Commercial Development & Marketing Comms\, Oxford BioDynamics)\, and Ewan Hunter (Chief Data and Technology Officer\, Oxford BioDynamics)\, who will discuss the development of their new blood-based assay\, the EpiSwitch CFS test\, and its potential impact on diagnosing and treating people with ME/CFS and Long Covid.
URL:https://solvecfs.org/event/from-mystery-to-measurable-the-science-behind-the-new-me-cfs-blood-test/
CATEGORIES:Long Covid,Research,Webinar
ATTACH;FMTTYPE=image/png:https://solvecfs.org/wp-content/uploads/2025/10/1.15.26-From-Mystery-to-Measurable.png
END:VEVENT
END:VCALENDAR